Stock Information
Qiagen NV (QGEN)
Ticker Symbol: QGEN
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $8,931.62 mil
Piotroski score: 7
PE Ratio: 16.253
EPS (TTM): 1.9963
Revenue (TTM): $9.57 M
Dividend Yield: 0.78531184720979%
ROE: 11.85%
Latest News
-
QIAGEN NV : Gets a Neutral rating from Barclays
Fri, May 8, 2026 3:27 AM
-
Transcript : Qiagen N.V. - Special Call
Thu, May 7, 2026 4:51 PM
-
TD Cowen Maintains Hold on Qiagen, Lowers Price Target to $40
Thu, May 7, 2026 3:47 PM
-
QIAGEN NV : Jefferies reaffirms its Buy rating
Thu, May 7, 2026 9:41 AM
-
Qiagen N : BofA Securities 2026 Healthcare Conference Investor introduction
Thu, May 7, 2026 7:57 AM
-
QIAGEN Plans To Advance QuantiFERON Latent TB Test With Automated Sample To Insight Workflow And Separate AI-Enabled Risk Stratification Tool For TB Progression
Thu, May 7, 2026 6:06 AM
-
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
Thu, May 7, 2026 6:02 AM
-
QIAGEN N.V. (NYSE:QGEN) Q1 Earnings Miss Estimates, Guidance Cut Sinks Stock
Wed, May 6, 2026 11:48 PM
-
UPDATE: Qiagen FY2026 expected to be more than $2.43 vs $2.51 Est; Affirms FY2026 Sales Guidance of $2.111B-$2.132B vs $2.183B Est
Wed, May 6, 2026 5:48 PM
-
Qiagen: Q1 Earnings Snapshot
Wed, May 6, 2026 5:48 PM
Key Financials
Financial data not available
